2009
DOI: 10.1016/j.ejps.2008.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Nanoaggregates of a random amphiphilic polyanion to carry water-insoluble clofazimine in neutral aqueous media

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(19 citation statements)
references
References 20 publications
0
19
0
Order By: Relevance
“…This possibility has been demonstrated by encapsulating clofazimine in a hydrophobized poly(methylvinylether- alt -maleic acid) (PMVEMAc). 123 Later, these authors extended this concept to biodegradable random amphiphilic polycations. 124 They prepared copolymers of of 5-Z-amino-δ-valerolactone (5-NHZVL) and ε- caprolactone (ε-CL).…”
Section: Amphiphilic Random Copolymers Based On Bio-derived Polymersmentioning
confidence: 99%
“…This possibility has been demonstrated by encapsulating clofazimine in a hydrophobized poly(methylvinylether- alt -maleic acid) (PMVEMAc). 123 Later, these authors extended this concept to biodegradable random amphiphilic polycations. 124 They prepared copolymers of of 5-Z-amino-δ-valerolactone (5-NHZVL) and ε- caprolactone (ε-CL).…”
Section: Amphiphilic Random Copolymers Based On Bio-derived Polymersmentioning
confidence: 99%
“…See DOI: 10 [18][19][20][21] have been attempted to improve the solubility and minimize the side-effects of CFZ. Additionally, encapsulation by drug delivery vehicles such as amphiphilic polymers, [22][23][24][25][26] liposomes, 27,28 and macrocyclic molecules 29,30 has also been considered as a promising solution for bioavailability improvement, and to confer probable benefits on the management of side effects. Among these novel drug delivery vehicles, macrocyclic molecules have recently stimulated great interest in the pharmaceutical research field, as complexation by such molecules may not only improve the physicochemical properties of an active pharmaceutical ingredient (API), but also may modulate the biological activities of encapsulated APIs.…”
Section: Introductionmentioning
confidence: 99%
“…Several strategies are commonly applied to improve poorly soluble drugs solubility namely prodrug formation, salt formation [6], complexation with cyclodextrins [3] or other macromolecules [1,7], formulation of amorphous dispersions [8], use of co-solvents or surfactants [9], formulation of liposomes [10] and nanosuspensions [11]. Although many types of nanoparticles are available for oral delivery, lipid nanoparticles and especially solid lipid nanoparticles (SLNs), have shown to be one of the most promising delivery systems to improve the oral bioavailability of hydrophobic drugs [12].…”
Section: Introductionmentioning
confidence: 99%